Target intelligence / Profile preview

Transcriptional repressor scratch 1 (SCRT1)

Target
SCRT1
Molecular classification
Transcription factor, Zinc finger protein, C2H2-type zinc finger
01

Overview

Transcriptional repressor scratch 1 (SCRT1) is a member of the zinc finger transcription factor family, specifically characterized as a C2H2-type zinc finger protein[3][5][9]. It functions primarily as a transcriptional repressor that binds to E-box DNA motifs (notably CAGGTG), modulating the activity of other basic helix-loop-helix (bHLH) transcription factors[5][9]. SCRT1 plays a significant role in neural differentiation by promoting the maturation of neural cells, and is implicated in the regulation of β-cell proliferation in the pancreas during development[1][3]. SCRT1 expression can be regulated by other transcriptional repressors such as REST, particularly during reprogramming of exocrine pancreatic cells to a β-like phenotype[1]. Although SCRT1 is essential for specific developmental processes, there are no current reports of drugs directly targeting this transcription factor, nor of its use as a clinical biomarker or its direct involvement in established therapeutic paradigms. While SCRT1 influences biological pathways relevant to cancer and neurodevelopment, there are no documented safety concerns or therapy-specific challenges associated with this molecule as a drug target[1][5][9].

Other names
Scratch 1SCRThScrtDKFZp547F072ZNF898Scratch homolog 1 zinc finger proteinscratch family zinc finger 1scratch homolog 1zinc finger protein SCRT1
02

Biological functions

Transcriptional repressionRegulation of neural differentiationRegulation of β-cell proliferation
03

Disease associations

Cancer (possible regulatory role in cell proliferation pathways)Neurodevelopmental disease (implied by role in neural differentiation)

Beyond the preview

Go deeper on Transcriptional repressor scratch 1 (SCRT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcriptional repressor scratch 1 (SCRT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call